Humacyte, Inc.
USD0.01
+0.00 (+1.60%)
CEO
Laura E. Niklason
IPO Date
2020-12-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.23
Market Cap
$0.01B
Volume
0.01M
| 8,500 |
| $3.35 |
| 16 Jun 2023 | Shukla Rajiv | director | A-Award | Acquired | 8,500 | $3.35 |
| 16 Jun 2023 | Windham-Bannister Susan Richards | director | A-Award | Acquired | 8,500 | $3.35 |
| 16 Jun 2023 | Binder Gordon M | director | A-Award | Acquired | 8,500 | $3.35 |
| 16 Jun 2023 | Constantino Michael T. | director | A-Award | Acquired | 8,500 | $3.35 |
| 19 May 2023 | Constantino Michael T. | director | P-Purchase | Acquired | 4,750 | $4.18 |
| 24 Nov 2021 | Constantino Michael T. | director | P-Purchase | Acquired | 2,300 | $10.79 |
| 24 Nov 2021 | Constantino Michael T. | director | P-Purchase | Acquired | 200 | $10.83 |
| 15 Oct 2021 | Pope Todd | director | A-Award | Acquired | 13,000 | $10.03 |